|
2012 Journal Article Continuous lenalidomide treatment for newly diagnosed multiple myelomaPalumbo, Antonio, Hajek, Roman, Delforge, Michel, Kropff, Martin, Petrucci, Maria Teresa, Catalano, John, Gisslinger, Heinz, Wiktor-Jędrzejczak, Wiesław, Zodelava, Mamia, Weisel, Katja, Cascavilla, Nicola, Iosava, Genadi, Cavo, Michele, Kloczko, Janusz, Bladé, Joan, Beksac, Meral, Spicka, Ivan, Plesner, Torben, Radke, Joergen, Langer, Christian, Ben Yehuda, Dina, Corso, Alessandro, Herbein, Lindsay, Yu, Zhinuan, Mei, Jay, Jacques, Christian, Dimopoulos, Meletios A., MM-015 Investigators and Mollee, Peter (2012). Continuous lenalidomide treatment for newly diagnosed multiple myeloma. The New England Journal of Medicine, 366 (19), 1759-1769. doi: 10.1056/NEJMoa1112704 |
|
2012 Journal Article Recommendations for standardized reporting of protein electrophoresis in Australia and New ZealandTate, Jillian, Caldwell, Grahame, Daly, James, Gillis, David, Jenkins, Margaret, Jovanovich, Sue, Martin, Helen, Steele, Richard, Wienholt, Louise and Mollee, Peter (2012). Recommendations for standardized reporting of protein electrophoresis in Australia and New Zealand. Annals of Clinical Biochemistry, 49 (3), 242-256. doi: 10.1258/acb.2011.011158 |
|
2012 Journal Article WT1 expression as a marker of minimal residual disease predicts outcome in acute myeloid leukemia when measured post-consolidationGray, James X., McMillen, Lyle, Mollee, Peter, Paul, Sanjoy, Lane, Steven, Bird, Robert, Gill, Devinder, Saal, Russell and Marlton, Paula (2012). WT1 expression as a marker of minimal residual disease predicts outcome in acute myeloid leukemia when measured post-consolidation. Leukemia Research, 36 (4), 453-458. doi: 10.1016/j.leukres.2011.09.005 |
|
2012 Journal Article Validation of whole blood impedance aggregometry as a new diagnostic tool for HIT: results of a large Australian studyMorel-Kopp, Marie-Christine, Tan, Chee Wee, Brighton, Timothy A., McRae, Simon, Baker, Ross, Huyen Tran, Mollee, Peter, Kershaw, Geoffrey, Joseph, Joanne and Ward, Christopher (2012). Validation of whole blood impedance aggregometry as a new diagnostic tool for HIT: results of a large Australian study. Thrombosis and Haemostasis, 107 (3), 575-583. doi: 10.1160/TH11-09-0631 |
|
2012 Journal Article Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): The prospective international multicentre phase 2 PTLD-1 trialTrappe, Ralf, Oertel, Stephan, Leblond, Veronique, Mollee, Peter, Sender, Monica, Reinke, Petra, Neuhaus, Ruth, Lehmkuhl, Hans, Horst, Heinz August, Salles, Gilles, Morschhauser, Franck, Jaccard, Arnaud, Lamy, Thierry, Leithäuser, Malte, Zimmermann, Heiner, Anagnostopoulos, Ioannis, Raphael, Martine, Riess, Hanno, Choquet, Sylvain and for the German PTLD Study Group and the European PTLD Network (2012). Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): The prospective international multicentre phase 2 PTLD-1 trial. The Lancet Oncology, 13 (2), 196-206. doi: 10.1016/S1470-2045(11)70300-X |
|
2012 Journal Article High dose methotrexate and extended hours high-flux hemodialysis for the treatment of primary central nervous system lymphoma in a patient with end stage renal diseaseMutsando, Howard, Fahim, Magid, Gill, Devinder S., Hawley, Carmel M., Johnson, David W., Maher, K. Gandhi, Marlton, Paula V., Mar Fan, Helen G. and Mollee, Peter N. (2012). High dose methotrexate and extended hours high-flux hemodialysis for the treatment of primary central nervous system lymphoma in a patient with end stage renal disease. American Journal of Blood Research, 2 (1), 66-70. |
|
2012 Conference Publication Outcomes and prognostic factors for patients with Acute Myeloid Leukemia admitted to the intensive care unitJackson, Kathryn A., Mollee, Peter, Morris, Kirk, Jackson, Dwane L., Kruger, Peter, Klein, Kerenaftali and Kennedy, Glen A. (2012). Outcomes and prognostic factors for patients with Acute Myeloid Leukemia admitted to the intensive care unit. 54th Annual Meeting and Exposition of the American Society of Hematology (ASH), Atlanta, GA, United States, 8-11 December 2012. Washington, DC, United States: American Society of Hematology. doi: 10.1182/blood.V120.21.3613.3613 |
|
2012 Conference Publication Intensive Chemotherapy for Acute Myeloid Leukemia in Elderly PatientsJackson, Kathryn A., Kennedy, Glen A., Mollee, Peter and Morris, Kirk (2012). Intensive Chemotherapy for Acute Myeloid Leukemia in Elderly Patients. 54th Annual Meeting and Exposition of the American Society of Hematology (ASH), Atlanta, GA, United States, 8-11 December 2012. Washington, DC, United States: American Society of Hematology. |
|
2011 Conference Publication Tissue microarray in DLBCL patients receiving R-CHOP chemo-immunotherapy shows survival benefit for coexpression of LMO2/BCL6Keane, Colm, Shen, Linda, Han, Erica, Nourse, Jamie P., Lea, Rod, Mollee, Peter, Gill, Devinder S. and Gandhi, Maher K. (2011). Tissue microarray in DLBCL patients receiving R-CHOP chemo-immunotherapy shows survival benefit for coexpression of LMO2/BCL6. 53rd ASH Annual Meeting, San Diego, CA United States, 10-13 December 2011. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood.v118.21.1585.1585 |
|
2011 Conference Publication A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosisMollee, Peter, Tiley, Campbell, Cunningham, Ilona, Moore, John, Prince, Miles, Cannell, Paul, Gibbons, Steve, Tate, Jill, Paul, Sanjoy and Gill, Devinder S (2011). A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis. 53rd ASH Annual Meeting, San Diego, 10-13 December 2011. American Society of Hematology. doi: 10.1182/blood.v118.21.3973.3973 |
|
2011 Conference Publication ZAP-70 expression measured by quantitative PCR (QPCR) as a prognostic marker in chronic lymphocytic leukaemia (CLL)Mollee, Peter, Banh, Raymond H., Cheung, Catherine, Saal, Russell, Chambers, Lynne, Pelly, Tennille and Gill, Devinder S (2011). ZAP-70 expression measured by quantitative PCR (QPCR) as a prognostic marker in chronic lymphocytic leukaemia (CLL). 53rd ASH Annual Meeting, San Diego, 10-13 December 2011. American Society of Hematology. doi: 10.1182/blood.v118.21.4602.4602 |
|
2011 Journal Article Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly expresses EBNA3A with conserved CD8 T-cell epitopesNguyen-Van, Do, Keane, Colm, Han, Erica, Jones, Kimberley, Nourse, Jamie P., Vari, Frank, Ross, Nathan, Crooks, Pauline, Ramuz, Olivier, Green, Michael, Griffith, Lyn, Trappe, Ralf, Grigg, Andrew, Mollee, Peter and Gandhi, Maher K. (2011). Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly expresses EBNA3A with conserved CD8 T-cell epitopes. American Journal of Blood Research, 1 (2), 146-159. |
|
2011 Journal Article Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trialCoiffier, Bertrand, Osmanov, Evgenii A., Hong, Xiaonan, Scheliga, Adriana, Mayer, Jiri, Offner, Fritz, Rule, Simon, Teixeira, Adriana, Walewski, Jan, de Vos, Sven, Crump, Michael, Shpilberg, Ofer, Esseltine, Dixie-Lee, Zhu, Eugene, Enny, Christopher, Theocharous, Panteli, van de Velde, Helgi, Elsayed, Yusri A., Zinzani, Pier Luigi, LYM-3001 study investigators and Mollee, Peter (2011). Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial. The Lancet Oncology, 12 (8), 773-84. doi: 10.1016/S1470-2045(11)70150-4 |
|
2011 Journal Article Catheter-associated bloodstream infection incidence and risk factors in adults with cancer: A prospective cohort studyMollee, P., Jones, M., Stackelroth, J., van Kuilenburg, R., Joubert, W., Faoagali, J., Looke, D., Harper, J. and Clements, A. (2011). Catheter-associated bloodstream infection incidence and risk factors in adults with cancer: A prospective cohort study. Journal of Hospital Infection, 78 (1), 26-30. doi: 10.1016/j.jhin.2011.01.018 |
|
2011 Journal Article Prognostic utility of spontaneous erythroid colony formation and JAK2 mutational analysis for thrombotic events in essential thrombocythaemiaWeston, H., Cowell, V., Grimmett, K., Saal, R., Jones, M., Mills, T., Gill, D., Marlton, P., Bird, R. and Mollee, P. (2011). Prognostic utility of spontaneous erythroid colony formation and JAK2 mutational analysis for thrombotic events in essential thrombocythaemia. Internal Medicine Journal, 41 (5), 408-415. doi: 10.1111/j.1445-5994.2010.02334.x |
|
2011 Conference Publication Rapid diagnosis of heparin-induced thrombocytopenia (HIT) by whole blood impedance aggregometry: results of the Australian multi centre studyMorel-Kopp, MC, Tan, CW, Brighton, T, McRae, S, Tran, H, Mollee, P, Kershaw, G, Joseph, J, Coyle, L and Ward, C (2011). Rapid diagnosis of heparin-induced thrombocytopenia (HIT) by whole blood impedance aggregometry: results of the Australian multi centre study. Unknown, unknown, unknown. HOBOKEN: WILEY-BLACKWELL. |
|
2011 Conference Publication Analytical aspects of standardised protein electrophoresis and immunofixation reportingTate, Jill, for the Working Party on Standardised Reporting of Protein Electrophoresis, Mollee, Peter, Caldwell, Grahame, Daly, James, Gillis, David, Jenkins, Margaret, Jovanovich, Sue, Martin, Helen, Steele, Richard and Wienholt, Louise (2011). Analytical aspects of standardised protein electrophoresis and immunofixation reporting. 35th Annual Scientific Meeting of the Australasian Division of the International Academy of Pathology, Sydney, NSW Australia, 4-6 June 2010. Oxford, United Kingdom: Elsevier. doi: 10.1016/s0031-3025(16)33167-1 |
|
2011 Conference Publication A Phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosisMollee, Peter, Tiley, Campbell, Cunningham, Ilona, Moore, John, Prince, Miles, Cannell, Paul, Gibbons, Steve, Tate, Jill, Paul, Sanjoy and Gill, Devinder S. (2011). A Phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis. 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH), San Diego, CA, United States, Dec 10-13, 2011. Washington, DC, United States: American Society of Hematology. |
|
2011 Journal Article Treatment of acute promyelocytic leukaemia in the Jehovah's Witness populationKeane, Colm, Mollee, Peter, Marlton, Paula and Gill, Devinder (2011). Treatment of acute promyelocytic leukaemia in the Jehovah's Witness population. Annals of Hematology, 90 (3), 359-360. doi: 10.1007/s00277-010-1023-0 |
|
2011 Conference Publication Recommendations for Standardised Reporting of Protein Electrophoresis in Australia and New ZealandTate, J., Mollee, P., Caldwell, G., Daly, J., Gillis, D., Jenkins, M., Jovanovich, S., Martin, H., Steele, R., Wienholt, L. and AACB Working Party Standardised Reporting of Protein Electrophoresis (2011). Recommendations for Standardised Reporting of Protein Electrophoresis in Australia and New Zealand. EuroMedLab Berlin 2011, Berlin, Germany, 15-19 May 2011. Berlin, Germany: Walter De Gruyter. doi: 10.1515/CCLM.2011.527 |
